| A comparative study on the measurement properties of Dermatology Life Quality Index (DLQI), DLQI‐Relevant and Skindex‐16 Á Szabó, V Brodszky, F Rencz British Journal of Dermatology 186 (3), 485-495, 2022 | 20 | 2022 |
| Questionnaire modifications and alternative scoring methods of the dermatology life quality index: a systematic review F Rencz, Á Szabó, V Brodszky Value in Health 24 (8), 1158-1171, 2021 | 15 | 2021 |
| A Rasch model analysis of two interpretations of ‘not relevant’responses on the Dermatology Life Quality Index (DLQI) F Rencz, AZ Mitev, Á Szabó, Z Beretzky, AK Poór, P Holló, N Wikonkál, ... Quality of Life Research 30, 2375-2386, 2021 | 15 | 2021 |
| Impact of interleukin-17 inhibitor therapy on arterial intima-media thickness among severe psoriatic patients ÉA Piros, Á Szabó, F Rencz, V Brodszky, K Szalai, N Galajda, ... Life 11 (9), 919, 2021 | 13 | 2021 |
| The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa A Bató, V Brodszky, LH Gergely, K Gáspár, N Wikonkál, Á Kinyó, Á Szabó, ... Quality of Life Research 30, 1477-1490, 2021 | 13 | 2021 |
| Anti-PD-1 Monotherapy in Advanced Melanoma—Real-World Data from a 77-Month-Long Retrospective Observational Study D Kuzmanovszki, N Kiss, B Tóth, T Kerner, V Tóth, J Szakonyi, K Lőrincz, ... Biomedicines 10 (7), 1737, 2022 | 11 | 2022 |
| General and skin-specific health-related quality of life in patients with atopic dermatitis before and during the COVID-19 pandemic K Koszorú, K Hajdu, V Brodszky, Á Szabó, J Borza, K Bodai, G Pónyai, ... Dermatitis 33 (6S1), S92-S103, 2022 | 9 | 2022 |
| Anti-interleukin-17 therapy of severe psoriatic patients results in an improvement of serum lipid and inflammatory parameters’ levels, but has no effect on body composition … ÉA Piros, Á Szabó, F Rencz, V Brodszky, N Wikonkál, P Miheller, ... Life 11 (6), 535, 2021 | 8 | 2021 |
| Értelmi sérültek fogászati állapotának felmérése I Szmirnova, G Szmirnov, F Rencz, Á Szabó, B Trimmel, Z Németh, ... Orvosi Hetilap 162 (42), 1698-1702, 2021 | 1 | 2021 |
| 080 The impact of atopic dermatitis on health-related quality of life K Koszorú, K Hajdu, J Borza, K Bodai, Á Szabó, A Bató, A Szegedi, ... Journal of Investigative Dermatology 141 (10), S162, 2021 | 1 | 2021 |
| Közgáz diáktudós-Kötődés és bizalom: Válogatás a BCE Közgáz Campus tudományos diákköri munkáiból BG Bognár, D Csábráki, T Csordás, M Granát, S Hadászi, AZ Mitev, ... Budapesti Corvinus Egyetem, 2022 | | 2022 |
| POSB379 Measurement Properties of DLQI, DLQI-R and Skindex-16: A Comparative Study S Ákos, V Brodszky, F Rencz Value in Health 25 (1), S235, 2022 | | 2022 |
| 047 Interleukin-17 inhibitor therapy reduces arterial intima-media thickness in severe psoriasis ÉA Piros, Á Szabó, F Rencz, V Brodszky, K Szalai, N Galajda, ... Journal of Investigative Dermatology 141 (10), S156, 2021 | | 2021 |
| PSY32 Health Utility Assessment By Composite Time Trade-Off in Patients with Hidradenitis Suppurativa PG Balázs, V Brodszky, B Jenei, Á Szabó, LH Gergely, K Gáspár, Á Kinyó, ... Value in Health 23, S748, 2020 | | 2020 |
| PSY31 The Relevance of'not Relevant'Responses on the Dlqi: A Rasch Analysis in Patients with Psoriasis F Rencz, AZ Mitev, Á Szabó, Z Beretzky, AK Poór, P Holló, M Sárdy, ... Value in Health 23, S748, 2020 | | 2020 |
| Módosított kérdőívváltozatok alkalmazása az egészségügyi finanszírozói döntéshozatalban Á Szabó BCE, 2020 | | 2020 |
